Dytfeld D, Costa L, Oriol A, Manier S, Voorhees P, Lin Y, Htut M, Roeloffzen W, Ho PJ, Shah U, Zhao M, Li Q, Balogh A, Li K, Slaughter A, Benachour N, Lonardi C, Ghosh A, Sun H, Lendvai N, Lengil T, Patel N, Koneru M, Florendo E, Filho OC, Mahajan V, Rodríguez-Otero P, Strouse C, Stewart A, Sidana S. P48 | LONG-TERM PROGRESSION-FREE SURVIVAL BENEFIT WITH CILTACABTAGENE AUTOLEUCEL IN STANDARD-RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14061.